Haleon (NYSE:HLN) Rating Lowered to “Equal Weight” at Morgan Stanley

Haleon (NYSE:HLN) was downgraded by investment analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research note issued on Friday, MarketBeat.com reports.

Several other brokerages have also recently weighed in on HLN. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday. UBS Group upgraded Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Price Performance

NYSE:HLN opened at $9.11 on Friday. The firm has a market cap of $41.24 billion, a P/E ratio of 26.79, a price-to-earnings-growth ratio of 2.95 and a beta of 0.29. The stock has a 50 day moving average of $9.59 and a two-hundred day moving average of $9.68. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in HLN. HighTower Advisors LLC raised its stake in shares of Haleon by 27.2% in the third quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after acquiring an additional 74,970 shares in the last quarter. Jane Street Group LLC raised its stake in Haleon by 1,689.4% in the third quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock valued at $2,803,000 after buying an additional 250,169 shares in the last quarter. Chartwell Investment Partners LLC raised its stake in Haleon by 107.8% in the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock valued at $5,030,000 after buying an additional 246,594 shares in the last quarter. Townsquare Capital LLC raised its stake in Haleon by 29.8% in the third quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock valued at $5,032,000 after buying an additional 109,217 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Haleon by 25.3% during the third quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock worth $53,791,000 after purchasing an additional 1,026,939 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.